Bile acid binding resin prevents fat accumulation through intestinal microbiota in high-fat diet-induced obesity in mice

Metabolism: Clinical and Experimental

Volumn 71, Issue , 2017, Pages 1-6

  Kusumoto, Yukie ^a   Irie, Junichiro ^a   Iwabu, Kaho ^a   Tagawa, Hirotsune ^a   Itoh, Arata ^a   Kato, Mari ^a   Kobayashi, Nana ^a   Tanaka, Kumiko ^a   Kikuchi, Rieko ^a   Fujita, Masataka ^a   Nakajima, Yuya ^a   Morimoto, Kohkichi ^a   Sugizaki, Taichi ^a   Yamada, Satoru ^b   Kawai, Toshihide ^a   Watanabe, Mitsuhiro ^a   Oike, Yuichi ^c   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY   (Japan)

^b KITASATO INSTITUTE HOSPITAL   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Bile acid; Intestinal microbiota; Obesity

Indexed keywords

ACETIC ACID; AMPICILLIN; BILE ACID; BILE ACID BINDING RESIN; BUTYRIC ACID; METRONIDAZOLE; NEOMYCIN; PROPIONIC ACID; RESIN; SHORT CHAIN FATTY ACID; SULFATE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; VANCOMYCIN; COLESTYRAMINE; FAT INTAKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEROIDES; CECUM; CLOSTRIDIUM; CLOSTRIDIUM LEPTUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MECHANISM; DYSBIOSIS; ENERGY EXPENDITURE; FECES MICROFLORA; GERMFREE MOUSE; INTESTINE FLORA; LIPID DIET; LIPID STORAGE; LOW FAT DIET; MALE; METABOLIC PARAMETERS; MICROFLORA; MOUSE; NONHUMAN; OBESITY; PREVOTELLA; PRIMARY PREVENTION; PRIORITY JOURNAL; ANIMAL; BACTERIAL LOAD; BAGG ALBINO MOUSE; DRUG EFFECTS; FAT INTAKE; GENE EXPRESSION REGULATION; METABOLISM; MICROBIOLOGY; WEIGHT GAIN;

ANIMALS; BACTERIAL LOAD; BACTEROIDES; BILE ACIDS AND SALTS; CECUM; CHOLESTYRAMINE RESIN; CLOSTRIDIUM; DIET, HIGH-FAT; DIETARY FATS; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED BALB C; OBESITY; PREVOTELLA; WEIGHT GAIN;

EID: 85014661146     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2017.02.011     Document Type: Article

References (20)

1. [1] Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., Diversity, stability and resilience of the human gut microbiota. Nature 489 (2012), 220–230.
2. [2] Turnbaugh, P.J., Backhed, F., Fulton, L., Gordon, J.I., Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3 (2008), 213–223.
3. [3] David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
4. [4] Islam, K.B., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 141 (2011), 1773–1781.
5. [5] Handelsman, Y., Role of bile acid sequestrants in the treatment of type 2 diabetes. Diabetes Care 34:Suppl. 2 (2011), S244–S250.
6. [6] Kobayashi, M., Ikegami, H., Fujisawa, T., Nojima, K., Kawabata, Y., Noso, S., et al. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin. Diabetes 56 (2007), 239–247.
7. [7] Watanabe, M., Morimoto, K., Houten, S.M., Kaneko-Iwasaki, N., Sugizaki, T., Horai, Y., et al. Bile acid binding resin improves metabolic control through the induction of energy expenditure. PLoS One, 7, 2012, e38286.
8. [8] Tagawa, H., Irie, J., Itoh, A., Kusumoto, Y., Kato, M., Kobayashi, N., et al. Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver. Diabetes Res Clin Pract 109 (2015), 85–94.
9. [9] Morimoto, K., Watanabe, M., Sugizaki, T., Irie, J., Itoh, H., Intestinal bile acid composition modulates prohormone convertase 1/3 (PC1/3) expression and consequent GLP-1 production in male mice. Endocrinology 157 (2016), 1071–1081.
10. [10] Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R., Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004), 229–241.
11. [11] Shimizu, N., Maruyama, T., Yoshikawa, N., Matsumiya, R., Ma, Y., Ito, N., et al. A muscle-liver-fat signalling axis essential for central control of adaptive adipose remodelling. Nat Commun, 6, 2015, 6693.
12. [12] Shimizu, I., Aprahamian, T., Kikuchi, R., Shimizu, A., Papanicolaou, K.N., Maclauchlan, S., et al. Vascular rarefaction mediates whitening of brown fat in obesity. J Clin Invest 124 (2014), 2099–2112.
13. [13] Nagashima, K., Hisada, T., Sato, M., Mochizuki, J., Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol 69 (2003), 1251–1262.
14. [14] Shiozaki, A., Yoneda, S., Yoneda, N., Yonezawa, R., Matsubayashi, T., Seo, G., et al. Intestinal microbiota is different in women with preterm birth: results from terminal restriction fragment length polymorphism analysis. PLoS One, 9, 2014, e111374.
15. [15] Hiraishi, A., Iwasaki, M., Shinjo, H., Terminal restriction pattern analysis of 16S rRNA genes for the characterization of bacterial communities of activated sludge. J Biosci Bioeng 90 (2000), 148–156.
16. [16] Larsen, N., Vogensen, F.K., van den Berg, F.W., Nielsen, D.S., Andreasen, A.S., Pedersen, B.K., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One, 5, 2010, e9085.
17. [17] Yoshifuji, A., Wakino, S., Irie, J., Tajima, T., Hasegawa, K., Kanda, T., et al. Gut lactobacillus protects against the progression of renal damage by modulating the gut environment in rats. Nephrol Dial Transplant 31 (2016), 401–412.
18. [18] Thompson, W.G., Thompson, G.R., Effect of cholestyramine on the absorption of vitamin D3 and calcium. Gut 10 (1969), 717–722.
19. [19] Harach, T., Pols, T.W., Nomura, M., Maida, A., Watanabe, M., Auwerx, J., et al. TGR5 potentiates GLP-1 secrestion in response to anionic exchange resins. Sci Rep, 2, 2012, 430.
20. [20] Macfarlane, S., Macfarlane, G.T., Regulation of short-chain fatty acid production. Proc Nutr Soc 62 (2003), 67–72.